<DOC>
	<DOCNO>NCT02490904</DOCNO>
	<brief_summary>Evaluate impact eplerenon ( administrated 4 day immediate pre-operative post-operative period ) graft function evaluate measurement glomerular filtration rate 3 month - variable strongly associate long term graft survival .</brief_summary>
	<brief_title>Eplerenone Patients Undergoing REnal Transplant ( EPURE TRANSPLANT )</brief_title>
	<detailed_description />
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Eplerenone</mesh_term>
	<mesh_term>Spironolactone</mesh_term>
	<criteria>Patients older 18 Informed consent Candidate single dual kidney transplantation expand criterion decease donor ( old 60 year age 50 59 2 3 follonwing criterion : cardiovascular death , history hypertension , creatinemia 130µmol/L ) , receving one two kidney , without conservation perfusion machine Chronic hemodialysis Affiliated social security system Multiple organs transplant ( kidney liver , kidney heart , kidney pancréas , kidney lung , kidney intestine ) Peritoneal dialysis Preemptive transplantation Hypersensitivity know allergy Eplerenon one excipients Patients severe hepatic insufficiency ( class ChildPugh C ) Patient receving powerful inhibitor CYP3A4 ( example itraconazole , kétoconazole , ritonavir , nelfinavir , clarithromycine , télithromycine néfazodone ) Hypersensitivity know allergy iodize contrast agent ( iohexol ) Demonstrated thyrotoxicosis Hypersensitivity lactose HLA desensitization prior renal transplantation Pregnant woman woman without efficient contraception Patient protection justice Patient guardianship Participation another biomedical study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Kidney transplantation</keyword>
	<keyword>Eplerenon</keyword>
</DOC>